Clinical Trials Logo

Clinical Trial Summary

Female chronic pelvic pain (CPP) is defined as the sensation of pain arising from the lower urinary tract, bowel, muscles, nerves, and gynecologic organs within the pelvis. It can also include menstrual pain and pain with intercourse, when these adversely affects a patient's well-being. Chronic pelvic pain is often associated with negative cognitive, behavioral, sexual and emotional consequences, which can include physical deconditioning, pain catastrophizing (magnifying the threat of pain), kinesiophobia (fear of movement), and depression. CPP has been estimated to affect between 5.7%-26.6% of women.Treatments for chronic pelvic pain are limited, and the use of centrally acting pain medications such as opioids is common. There is increasing awareness of the risks of these medications, including dependence, addiction, and over-dose related death. Therefore, it is critical to look for safe alternatives to manage chronic pelvic pain. Exercise has been targeted as a treatment strategy for chronic pain conditions, improving both pain intensity and physical function. Studies have demonstrated that yoga, Zumba®, and treadmill walking can improve menstrual related pain and quality of life. Mindfulness is the non-judgmental acceptance and investigation of present experience, including body sensations, internal mental states, thoughts, emotions, impulses, and memories to reduce suffering or distress and to increase well-being. Prior research by our group has demonstrated efficacy of mindfulness meditation in reducing pain and improving quality of life in women with chronic pelvic pain. Mindful movement is putting attention into what the body is feeling as it moves. It involves paying attention movement that feels good as well as to early warning signs that an exercise may be too intense or may cause a pain flare. This study is a 12-week program of gentle aerobic exercise and stretching for patients with CPP that applies mindful movement practices. Patients will be randomized to weekly classes versus the routine recommendations for exercise. We will measure pain reduction, improvement in quality of life, and reduction in pain catastrophizing and kinesiophobia.


Clinical Trial Description

Chronic pelvic pain (CPP) is defined as the sensation of pain arising from the lower urinary tract, bowel, pelvic floor, myofascial, and reproductive structures and includes cyclic pain and pain with intercourse, when the condition adversely affects a patient's wellbeing. Chronic pelvic pain is often associated with negative cognitive, behavioral,sexual and emotional consequences, which can include physical deconditioning, pain catastrophizing, kinesiophobia, and depression. CPP has been estimated to affect between 5.7%-26.6% of women. Treatments for pelvic pain include management of peripheral pain sources, as well as targeting the centrally mediated response to pain. The use of centrally acting pain medications, including opioids, is common in patients with pelvic pain. There is increasing literature recommending against the use of opioids for chronic pain, citing risks of dependence, addiction, and over-dose related death. Therefore, it is critical to look for safe alternatives to manage chronic pelvic pain. Exercise has been targeted as a treatment strategy for chronic pain conditions, improving both pain intensity and physical function. Multiple studies have demonstrated that yoga, Zumba®, and treadmill walking can improve menstrual-related pain in young women with dysmenorrhea. In addition to pain reduction, studies have also demonstrated improvement in quality of life. Mindfulness is the non-judgmental acceptance and investigation of present experience, including body sensations, internal mental states, thoughts, emotions, impulses, and memories to reduce suffering or distress and to increase well-being. Prior research by our group has demonstrated efficacy of mindfulness meditation in reducing pain and improving quality of life in women with chronic pelvic pain. Mindful movement is putting attention into what the body is feeling as it moves. It involves paying attention movement that feels good as well as to early warning signs that an exercise may be too intense or may cause a pain flare. This study is a 12-week program of aerobic exercise and stretching for patients with CPP that applies mindful movement practices. Patients will be randomized to weekly classes versus routine recommendations for exercise. We will measure pain reduction, improvement in quality of life, and reduction in pain catastrophizing and kinesiophobia. We will enroll patients with chronic pelvic pain of at least 6-months duration who have not engaged in regular physical activity in the prior 3 months. Patients aged 18 or older receiving care in the Pelvic Pain Program at the WMC will be invited to take part in the study. Records for patients in the pelvic pain program who are presenting for care will be reviewed for eligibility and approached prior to their visit about potentially participating in the study. Additionally, charts for patients active in the pelvic pain program will be reviewed for eligibility and the research assistant contact participants about participation in the study. If patients are interested in the study and do not have an upcoming office visit, they will be scheduled to come in to meet with the research assistant and be consented for the study. Subjects will also be consented at the time of their office visits. Study methods: 1. 60 patients with a history of CPP who meet the inclusion and exclusion criteria will be recruited and randomly assigned to the mindful movement program (N=30) or routine care (N=30). 2. All subjects will watch a video, created by our program for the pelvic pain population, which will review safety measures for starting an exercise program. The video includes how to start and gently increase duration of exercise and modifications that can be used to safely exercise with pain. All subjects will receive a step tracker and a study journal. 3. Patients randomized to the study arm will get a prescription for aerobic mindful exercise and stretching 4 days a week. They will view additional videos, created by our program, about mindful movement, awareness of body cues, intentional movement, and body scans. The scripts for the videos are submitted to the IRB for approval. They will have access to exercise classes as described below that are geared toward participants with physical limitations. All classes will incorporate reminders regarding mindful movement practices, as teachers will be selected who have an understanding of this principle. Participants will be instructed to attend an in person or virtual class at least once a week. A variety of 20-60 minute classes will be available. Participants will be reminded to listen to their body's cues and be given options to modify their movement. Additionally, participants will work towards completing at least 20 minutes of walking followed by 5-10 minutes of stretching 3 days a week. Participants can attend additional classes instead of walking. Participants are instructed to work toward a goal of at least. 80 minutes of cardiovascular exercise along with stretching each week. Participants will be required to track their activity with a study journal and step tracker provided through the study. a. Walking exercise with stretching: Participants will be recommended to walk on a treadmill, outside, or indoor location for at least 20 minutes, at a pace brisk enough to elevate ones heart rate. Participants are instructed to gently stretch their muscles following this activity for approximately 5-10 minutes. b. Yoga is a physical and mental practice with ancient roots. Modern yoga generally intends to build strength, stamina, flexibility, coordination and balance through a series of poses. c. Shake your Soul® is a movement practice that was developed with mindfulness practices in mind. It incorporates fluid dance repertoire set to world music. Classes cannot be recorded. d. Zumba® is a dance exercise class that features Latin and World rhythms. It provides a total workout, combining cardio, muscle conditioning, balance, and flexibility. Lower impact versons, such as Zumba Gold® have been designed to meet the needs of seniors and others who need lower impact activity. Classes cannot be recorded 4. Weekly phone calls with the research assistant will include collection of pain scores and will review barriers to exercise, pain issues related to the exercise and mindful approach to exercise. If a participant feels they may have an injury or are unable to continue the program, Dr. Clark Donat or Dr. Fox will be notified and follow up accordingly. 5. Patients randomized to the control arm will receive routine care within the pelvic pain program. As part of routine care, patients are counseled on the importance of movement and encouraged to engage in gentle activity. They will be given access to the introductory video. Participants will be encouraged to walk or engage in some form of cardiovascular exercise for at least 20 minutes a day, 4 days a week, and gently stretch for 5-10 minutes after their exercise. Participants are instructed to increase work toward a goal of at least. 80 minutes of cardiovascular exercise along with stretching each week. Participants will be encouraged to reach out to the study team if they feels they may have an injury or are unable to continue the program, Dr. Clark Donat or Dr. Fox will be notified and follow up accordingly. 6. Pain scores will be obtained using an 11-point NPS by the research assistant at the initial visit and during weekly phone check-ins. 7. Quality of life will be assessed using the World Health Organization Quality of Life -BREF questionnaire, a 26-item validated tool that addresses 4 domains: physical health, psychological health, social relationships, and environmental health [21]. Kinesiophobia will be assessed using the validated Tampa Scale for Kinesiophobia, a 17-item tool that indicates the level of fear associated with movement [22]. Pain catastrophizing will be assessed using the Pain Catastrophizing Scale, a validated 13- item tool that examines three subscales: magnification, rumination and helplessness [23]. These tools will be administered at enrollment and week 12. 8. Patient charts will be reviewed for demographics information, pain diagnoses and treatments, and medical and surgical history. Summary Study Outline following randomization Study Arm (1) vs. Control Arm (2) Initial exercise video 1. Yes- prior to initiation of 12 week program 2. Yes- prior to initiation of 12 week program Step tracker and study journal 1. Yes- prior to initiation of 12 week program 2. Yes- prior to initiation of 12 week program Mindful Movement video 1. Yes- prior to initiation of 12 week program 2. No Prescription for weekly exercise 1. Yes- 4 days a week with a goal of 80 minutes of cardiovascular exercise plus stretching a week: including at least one class 2. No, but participants will be encouraged to exercise 4 days a week with a goal of 80 minutes of cardiovascular exercise plus stretching each week. Weekly Phone calls by research assistant 1. Yes- with follow up by Drs. Clark Donat or Fox as indicated 2. No Assessment of Pain scores 1. Yes- at intake and weekly by RA 2. Yes- at intake and at conclusion of study Questionnaires 1. Yes- At enrollment and week 12 via RedCap 2. Yes- At enrollment and week 12 via RedCap Benefits: Study subjects may benefit from improved pain levels, improved quality of life, and increased fitness level. They may also benefit from developing increased insight about how movement helps their pain and how to understand their bodies signal in relationship to exercise. Risks: There is limited risk to the subjects who choose to participate in this study. All recruited patients will already be undergoing care for their chronic pelvic pain, and therefore being counseled generally on the importance of gentle exercise and movement. New exercise can be associated with musculoskeletal soreness or injury, some participants may notice changes in their bowel or bladder habits, and participants could experience dehydration. To minimize these risks and prepare participants for these side effects, the exercise will be slow and gentle with incorporated stretching, participants will be counseled on adequate hydration, and made aware that bowel and bladder changes may be encountered. As part of the weekly check in calls the research assistant will screen for possible side effects from exercise and provide appropriate information or alter the providers to contact the patient. Potential Obstacles: Studies of patients with CPP often have a low completion rate because of chronic pain and life stressors [16]. We hope that this program of mindful movement, with a slow and gentle increase in duration, will help to allow more subjects to continue this program. In addition, we will be providing a small stipend to help encourage completion of the study. Since much of the exercise will be available virtually, there may be a barrier with poor access to the internet. However, patients will be given the option of a walking program that can be completed independently. Lastly, pain catastrophizing and kinesiophobia may also be barriers for this study. We hope that our gentle approach to exercise will allow patient to engage in the program. Additionally, we will monitor patient experience with pain catastrophizing and kinesiophobia as a study outcome. Confidentiality of Data: Medical records of all patients enrolling in the study will be reviewed for demographic and health related information. Protected Health Information (PHI) obtained will include patient's name and date of birth. Additionally, information from the questionnaires will be obtained. All information will be kept in a REDCAP database. Responses to the questionnaires will be put into the database, and all hard copies will be discarded. After data collection is complete, all data will be de-identified and a key to allow the information to be linked to the appropriate patient will be kept in a separate, password-protected database on a Lifespan computer. The de-identified database will be used for statistical analysis and presentation of data to the team, in order to maintain HIPPA compliance. Hard copies of the consent forms will be kept in a locked file cabinet in Dr. Sarah Fox's office. The final data will be analyzed and published in a group format, and will not be traceable to specific patients. No information about sensitive or illegal behavior will be obtained. Participate compensation: All subjects will be given a fitness tracker valued at $30, They will also be compensated $25 for completion of the surveys at 6 and 12 weeks. Additionally, participants who are randomized to the study arm will receive access to virtual and in person exercise classes free of charge. Timeline: In preparation for this application, the PI reviewed records of the patients seen in the Pelvic Pain Program for the month of September 2021. 27 patients seen in that month would have been eligible for the study. For this reason, we are confident that we would be able to recruit and randomize our target of 60 patients within 6 months of beginning recruitment. Research Team:The investigators all have extensive experience caring for patients with chronic pain conditions. We have worked together clinically for up to 12 years and have been actively involved in research on mindfulness for the past 4 years. The current research team previously studied mindfulness meditation for CPP so they have experience with this patient population and have already established successful collaboration [16]. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05899088
Study type Interventional
Source The Miriam Hospital
Contact Lindsay Clark Donat, MD, FACOG
Phone (401) 606-3000
Email lindsay.clarkdonat@lifespan.org
Status Not yet recruiting
Phase N/A
Start date June 2023
Completion date March 2024

See also
  Status Clinical Trial Phase
Completed NCT01931670 - A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Phase 3
Recruiting NCT05648669 - A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain Phase 3
Completed NCT04081532 - The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain N/A
Recruiting NCT06101303 - Endometriosis Pain
Completed NCT04665414 - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Completed NCT03690765 - Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
Recruiting NCT05153512 - ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
Active, not recruiting NCT04171297 - Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Completed NCT04565470 - Strategies of Self-management of Endometriosis Symptoms
Completed NCT03613298 - Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement. N/A
Withdrawn NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Not yet recruiting NCT03464799 - Does Immunotherapy Have a Role in the Management of Endometriosis?
Active, not recruiting NCT03002870 - Characteristics of Patient Population With Endometriosis N/A
Completed NCT02973854 - Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Recruiting NCT02481739 - Laparoscopic Surgical Management of Endometriosis on Fertility N/A
Active, not recruiting NCT02754648 - Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve N/A
Completed NCT06106932 - GnRH-a on Angiogenesis of Endometriosis N/A
Completed NCT02387931 - Supplementation in Adolescent Girls With Endometriosis Phase 4